December 5, 2024, 12-2 PM
Johns Hopkins Bloomberg Center
555 Pennsylvania Avenue NW, Washington, DC 20001
About the Event
The Foundation for mRNA Medicines invites you to participate in a forum at the Johns Hopkins Bloomberg Center. Co-hosted by the Foundation, the Alliance for mRNA Medicines, and the JHU Science Diplomacy Hub, the forum will feature discussions led by thought leaders and experts about mRNA’s promise to improve human health and the threat that mis- and dis-information poses to scientific advancement in this field.
To register, please contact Ashley Hudak at [email protected].
Speakers
Katalin Kariko, PhD
Nobel Prize 2023, Medicine Adjunct Professor of Neurosurgery, Penn Medicine
John Cooke, MD, PhD
Medical Director of the RNA Therapeutics Program, Houston Methodist DeBakey Heart and Vascular Center
Thomas Inglesby, MD
Director, Johns Hopkins Center for Health Security, Bloomberg School of Public Health
Walter Straus, MD
Vice President, Safety & Pharmacovigilance, Moderna
Additional speakers to be announced.
Why Attend?
The event will bring together academic leaders, members of the mRNA community, and US policymakers, including Congressional staff and executive branch leaders, to engage in meaningful knowledge exchange, discussion, and education.
Attendees will:
- Learn more about the promising research harnessing mRNA to develop vaccines and therapeutics to address cancer, rare diseases, neurological disorders, gene editing, infectious diseases and more
- Discuss the threats to advancements in mRNA medicines and technologies posed by misinformation
- Lay the groundwork for a collaborative education campaign
About the Foundation for mRNA Medicines
The mission of the Foundation for mRNA Medicines is to promote the development and advancement of mRNA-based vaccines and therapeutics through public education and awareness, combatting misinformation, and training and advancement of the scientific professionals in this field. The Foundation champions projects and programs consistent with its mission to harness the promise of this technology for the benefit of individual patients, the scientific community, and public health as a whole.